PD-L1 is an activation-independent marker of brown adipocytes

por Jessica R. Ingram, Michael Dougan, Mohammad Rashidian, Marko Knoll, Edmund J. Keliher, Sarah Garrett, Scott Garforth, Olga S. Blomberg, Camilo Espinosa, Atul Bhan, Steven C. Almo, Ralph Weissleder, Harvey Lodish, Stephanie K. Dougan, Hidde L. Ploegh
Publicado 2017

Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer

por Michael Dougan, Justine Cohen, Dejan Juric, Leyre Zubiri, Ryan J Sullivan, Daniel A Zlotoff, Yevgeniy R Semenov, Sara R Schoenfeld, Genevieve M Boland, Amanda C Guidon, Laura Petrillo, Alexandra-Chloe Villani, Gabriel E Molina, Sienna M Durbin, Molly F Thomas, Alex T Faje, Michelle Rengarajan, Daniel Okin, Benjamin D Medoff, Mazen Nasrallah, Minna J Kohler, Jocelyn R Farmer, Aditya Bardia, Steven M Blum, Rebecca K Leaf
Publicado 2021

SARS-CoV-2 viral load is associated with increased disease severity and mortality

por Jesse Fajnzylber, James Regan, Kendyll Coxen, Heather Corry, Colline Wong, Alexandra Rosenthal, Daniel Worrall, Francoise Giguel, Alicja Piechocka-Trocha, Caroline Atyeo, Stephanie Fischinger, Andrew Chan, Keith T. Flaherty, Kathryn Hall, Michael Dougan, Edward T. Ryan, Elizabeth Gillespie, Rida Chishti, Yijia Li, Nikolaus Jilg, Dusan Hanidziar, Rebecca M. Baron, Lindsey Baden, Athe M. Tsibris, Katrina A. Armstrong, Daniel R. Kuritzkes, Galit Alter, Bruce D. Walker, Xu Yu, Jonathan Z. Li, The Massachusetts Consortium for Pathogen Readiness
Publicado 2020